1. Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies
   Tauben Averbuch et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
2. Advances in the Study of Renal Cardiac Lesions in Fabry Disease
   占渝 袁, 2023, Advances in Clinical Medicine CrossRef
3. Biomarkers in anderson-Fabry disease: what should we use in the clinical practice?
   Patrício Aguiar, 2024, Rare Disease and Orphan Drugs Journal CrossRef
4. Long-Chain Base (LCB)-Targeted Lipidomics Study Uncovering the Presence of a Variety of LCBs in Mammalian Blood
   Mari Ohira et al, 2020, Separations CrossRef
5. SCREENING DIAGNOSTICS OF FABRIC DISEASE AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE IN THE NORTH-WESTERN REGION OF RUSSIA
   K. A. Vishnevskii et al, 2019, Nephrology (Saint-Petersburg) CrossRef
6. Metabolomic Studies of Lipid Storage Disorders, with Special Reference to Niemann-Pick Type C Disease: A Critical Review with Future Perspectives
   Benita Claire Percival et al, 2020, International Journal of Molecular Sciences CrossRef
7. Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up
   Clara Carnicer-Cáceres et al, 2021, Journal of Clinical Medicine CrossRef
8. Restrictive cardiomyopathy in a patient with systemic sclerosis and Fabry disease: a case-based review
   Álvaro Arbeláez-Cortés et al, 2020, Rheumatology International CrossRef
9. Metabolic Fingerprinting of Fabry Disease: Diagnostic and Prognostic Aspects
   Maria Teresa Rocchetti et al, 2022, Metabolites CrossRef
10. Modern Approach to Fabry Disease Diagnosis and Management in Children
    Olga Ya. Smirnova et al, 2024, Current Pediatrics CrossRef